687 filings
8-K
ZVRA
Zevra Therapeutics Inc
26 Mar 24
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of
8:28pm
8-K
ZVRA
Zevra Therapeutics Inc
5 Mar 24
Regulation FD Disclosure
7:34am
8-K
ZVRA
Zevra Therapeutics Inc
4 Mar 24
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
8:24am
8-K
ZVRA
Zevra Therapeutics Inc
28 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:29pm
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
ZEVRA THERAPEUTICS / Nantahala Capital Management ownership change
4:51pm
8-K/A
jmnk doq4qz4no
5 Feb 24
Financial Statements and Exhibits
12:00am
4
syl6iah7yfkzqsrh2qp
2 Feb 24
ZEVRA THERAPEUTICS / Joshua Schafer ownership change
9:22pm
4
vcpvfm
2 Feb 24
ZEVRA THERAPEUTICS / Timothy J. Sangiovanni ownership change
8:17pm
4
slxeoqe0
2 Feb 24
ZEVRA THERAPEUTICS / Christal M M Mickle ownership change
8:14pm
4
vd474r
2 Feb 24
ZEVRA THERAPEUTICS / Sven Guenther ownership change
8:13pm
4
5omfooq w60q6lh
2 Feb 24
ZEVRA THERAPEUTICS / R. LaDuane Clifton ownership change
8:11pm
4
df70 a93l8s7n2uc
2 Feb 24
ZEVRA THERAPEUTICS / Neil F. McFarlane ownership change
8:10pm
4
bulcexfh4 mobvfxnd
2 Feb 24
ZEVRA THERAPEUTICS / Alvin Shih ownership change
8:08pm
3
2t3hzu fnrfky
2 Feb 24
ZEVRA THERAPEUTICS / Alvin Shih ownership change
7:13am
SC 13G
ey7a9gtby
29 Jan 24
ZEVRA THERAPEUTICS / BlackRock ownership change
5:25pm
8-K
ty04g2a67o1ifsnci
23 Jan 24
Departure of Directors or Certain Officers
7:37am
8-K
bwdo4z6heve
8 Jan 24
Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
8:03am
8-K
wbji 3pe4
27 Dec 23
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
7:48am
424B5
lsnvfr76
21 Nov 23
Prospectus supplement for primary offering
7:40pm